Are Analyst Price Targets Accurate? 7 Years of Data
How often Wall Street price targets are reached, how long it takes, and how the promised upside compares with what stocks actually did. From Exent’s backtest of 628,792 analyst ratings.
How often Austin Yun’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 0 ratings, compared with the average Wall Street analyst.
Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.
Austin Yun of Macquarie ranks #978 of the 1,000 analysts Exent scores, with a 4.3★ rating and a focus on materials. Over a 7‑year lookback, — of Austin’s price targets were reached, the 52.4% average across all analysts.
| Metric | Austin Yun | All analysts |
|---|---|---|
| Price‑target hit rate | — | 52.4% |
| Median days to hit target | — | 91 days |
| Calls up after 12 months | — | 64.0% |
| Median 12‑month return of calls | — | +13.4% |
| Hit rate, last 2 years | — | — |
| Average worst drop after a call | — | — |
| Ratings in the sample | 0 | — |
| Stocks covered | 12 | — |
The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.
| Time to reach the target | Austin Yun |
|---|---|
| Under 30 days | — |
| 30–90 days | — |
| 90–180 days | — |
| Over 180 days | — |
Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.
| Stock | Ratings in the sample |
|---|---|
| ASX-LYC | 77 |
| ASX-PLS | 68 |
| ASX-ELV | 59 |
| ASX-GL1 | 41 |
| ASX-LTR | 31 |
| AIM-ALL | 30 |
| ASX-PMT | 24 |
| ASX-ILU | 23 |
In the past year Austin’s ratings were 67% Buy, 32% Hold and 1% Sell.
| Date | Stock | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 13, 2026 | AIM-ALL | Reiterated: Hold | Hold | $18.58 |
| Sep 13, 2026 | ASX-NIC | Reiterated: Buy | Buy | $1.25 |
| Sep 13, 2026 | ASX-ELV | Reiterated: Buy | Buy | $12.50 |
| Sep 13, 2026 | ASX-PLS | Reiterated: Buy | Buy | $6.00 |
| Sep 13, 2026 | ASX-GL1 | Reiterated: Buy | Buy | $0.85 |
| Sep 13, 2026 | ASX-WC8 | Reiterated: Buy | Buy | $0.90 |
| Sep 13, 2026 | ASX-IGO | Reiterated: Buy | Buy | $9.50 |
| Sep 13, 2026 | ASX-PMT | Reiterated: Buy | Buy | $0.70 |
| Sep 13, 2026 | ASX-LTR | Reiterated: Buy | Buy | $1.50 |
| Sep 7, 2026 | ASX-LYC | Reiterated: Buy | Buy | $20.50 |
| Sep 1, 2026 | ASX-LTR | Reiterated: Buy | Buy | $1.50 |
| Aug 31, 2026 | ASX-ELV | Reiterated: Buy | Buy | $12.50 |
Austin’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.
Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?
Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.
By Exent’s scoring Austin Yun ranks #978 of 1,000 with a 4.3★ rating. — of price targets were reached over a 7-year lookback (all analysts: 52.4%), and — of calls were up 12 months later. Past accuracy does not guarantee future accuracy.
Austin Yun’s success rate is 40.6% by the ranking source and — by Exent’s price-target hit-rate backtest, with a median of — days to reach a target.
Austin Yun (Macquarie) covers 12 stocks, mostly in materials. The most frequently rated are ASX-LYC, ASX-PLS, ASX-ELV, ASX-GL1, ASX-LTR.
Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.
Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.